Neuphoria Therapeutics (NEUP) logo

Neuphoria Therapeutics (NEUP) stock

Market cap $18.3MShares as of Sep 17

$3.38
-1.74%

As of Monday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score NEUP. It is too small and too thinly traded for a fair Quality Score.

Healthcare · Biotech

Next2H 2026“…2026 Anticipated regulatory submissions EMA, Canada, Australia May 2026 Initiate Phase 3 in Q3 2026 H2 2026…”Trial start · SEC filing · Jul 24
Cash$19.9M in cash. One of the last four quarters brought cash in while the others used it.On Jun 30 · the company says “into 2029”

Follow NEUP's news. Pro members can get an alert when Neuphoria Therapeutics files news, and see its trials, share raises, and its CEO's filings.

Get an alert when NEUP files newsSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,191 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

Cash$19.9M in cash. One of the last four quarters brought cash in while the others used it.On Jun 30 · the company says “into 2029”

What's next for NEUP, and how long its cash lasts

Next step the company has named

2H 2026“…to MHRA Apr 2026 Anticipated regulatory submissions EMA, Canada, Australia May 2026 Initiate Phase 3 in Q3 2026 H2 2026 PFS data with potential for accelerated approval in…”Trial start · SEC filing · Jul 24

What it means: when a trial begins, or reaches the stage the company named.

For Pro members: 3 more milestones and 26 filings.

Cash runway Jun 30 balance sheet

$19.9M in cash

One of the last four quarters brought cash in while the others used it, so an average says little about the next.

What it means: a runway is counted only when each of the last four quarters used cash. The company's estimate is “into 2029” (8-K, Jul 24).

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

  • Shelf registration (S-3, filed Nov 18, 2024)
  • At-the-market share sales program (S-3, filed Nov 18, 2024)

For Pro members: the amounts, and the share count against a year ago.

Insiders

No open-market buys or sales by its officers or directors in their filings of the last year.

From Form 4: open-market buys and sales only.

For Pro members: every trade, and Spyros Papapetropoulos’s 4 filings and quotes.

Get an alert when NEUP files newsSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

10 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 168 dates, ranked →

NEUP's latest filings

11 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why NEUP isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. NEUP is worth about $18.3M and trades about 22,000 shares a day. A stock that clears every mark is scored from the next weekly rebuild.

Straight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

The price on this page is delayed at least 15 minutes.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.